Comprehensive Digestive Stool Analysis

This test evaluates digestion, absorption, gut flora, and the colonic environment. This profile is indicated for all chronic GI problems, for acute bowel pattern changes, and for many systemic diseases and provides a sensitivity panel for treating pathogenic flora. Additionally, Genova offers a parasitology component with the CDSA test that evaluates for parasites using microscopic examination and EIA testing.

Specimen Requirements:  1 Cary Blair, 1 Formalin; 40ml stool in white-top cup.

Comprehensive Digestive Stool Analysis / Parasitology ™(CDSA/P)
The Comprehensive Digestive Stool Analysis / Parasitology (CDSA/P) is a stool test which offers a comprehensive look at the overall health of the gastrointestinal (GI) tract. The CDSA/P is the original non-invasive evaluation of gastrointestinal function that includes analyses of digestion, absorption, bacterial balance, and yeast. Additionally, the CDSA/P gastrointestinal stool analysis tests for parasites. This gastrointestinal stool analysis profile is recommended for patients with diffuse and non-specific GI-related symptoms such as IBS, indigestion, dysbiosis, constipation, and diarrhoea.

Consequences of Imbalanced Gastrointestinal Health:

  • Irritable Bowel Syndrome (IBS) can be the result of maldigestion, malabsorption, dysbiosis, and/or inflammation
  • Maldigestion can result in GI symptoms such as gas, bloating, abdominal pain, constipation or diarrhea
  • Chronic maldigestion can lead to bacterial/fungal overgrowth and alterations in gut permeability.  Toxins and large molecules that escape the intestinal barrier can enter the general circulation, inflame the liver, burden the body’s detoxification system, and increase the risk for food allergies, joint disease, and imbalances in overall health.
  • Malabsorption can lead to deficiencies of nutrients, proteins, carbohydrates, and fats.  This can result in long term health complications such as anemia, malnutrition, impaired metabolism and other diseases, such as osteoporosis.
  • Chronic dysbiosis can lower the levels of beneficial short chain fatty acids and alter bacterial metabolic activity, thereby increasing the risk of carcinogenesis, hormonal imbalance, and GI inflammation
  • Altered GI immune function and exposure to bacterial pathogens can lead to diarrhea, mucosal inflammation, intestinal permeability, toxin production, and auto-immune disorders.

Specimen Requirements:  5cc stool in each vial – 1 Formalin, 1 Cary Blair, 3 SAF vials, and 1 white-top cup (for Add-ons). May be random stool, purge, or swab.

Circulating Tumour Cells (CTCs) sparked scientific